future seminars
recent seminars
Chronic pain is a highly unmet medical need, and also the subject of a large and costly category of legal claims. Yet, the invisibility, unspeakability, and subjectivity of pain have caused it to be a subject of as much philosophical and legal controversy on its significance.
Most recently, several new neuroimaging technologies are promising to solve these problems, by rendering pain visible, measurable, and to some degree, verifiable.
In this presentation I describe the most recent developments of neuroimaging and analysing their possible implications for the law.
University of Birmingham
You can have a look here at the poster that Silvia and Barbara Bottalico will present at the meeting on Neuroethics and law that will be held in Padova, May 5-7, 2010 (http://neuroetica.psy.unipd.it/)
University of Padova
You can have a look at the program of the conference here .
Palace of Justice, Milan.
You can have a look at the program of the conference here .
Seminar for the 200th anniversary of Sir Charles Darwin's birth, where I talk about the future of the human species in the XXI century, of pre-implantation diagnosis, designer babies, and of different kinds of human enhancement including brain cognitive drugs). You can see the schedule of the 'Aperitivi with Darwin' here and download the power point presentation as a pfd file here .
Diagonal, Forli
How is the human embryology research regulated in the United Kingdom? I here discuss the role of the Human Fertilisation & Embryology Authority and the current Parliamentary debate onthe update of the 1990 Human Fertilisation & Embryology Act. I also discuss in detail the decisional process that brought to the "green light" to cybrid research, and the ethical issues pro and against. Click here to download the power point presentation.
University of Forlì (Bologna), Faculty of Political Sciences.
Personal Genomics has become reality: the Personal Genome Project, 1000 Genomes Project, direct to consumer genetic testings on the web. All of this challenges traditional noctions of privacy and informed consent. How does the law in the US and Europe cope with these new realities? Click here to download the presentation.
University of Bologna, Faculty of Medicine,
The ethical issued raised by research on cytoplasmic hybrid embryos. The decisional process in the UK, the HFEA resolution and its ethical justification. You can see the poster here .
ESTOOLS conference, Lund, Sweden
Is the ethical debate catching up with recent scientific advances? You can see the pdf presentation here.
Rijeka, Croatia (IX World Bioethics Conference)
In this seminar I try to answer the question whether the decision of the British Human Fertilisation and Embryology Authority (HFEA) on the permissibility of research on cytoplasmic hybrid embryos (cybrids) is sound from an ethical point of view. I take into account recent developments of the debate.You can see the pdf presentation here
University of Bologna, Faculty of Medicine, Aula Didattica Polo Murri at 3pm
In my commentary to James A. Marcum's talk on the debate holism vs reductionism in cancer biology, I point out how cancer is a complex system , where multiple and different causes can lead through different, unique instances to the same result, a tumor. Each cancer is a new state that results from a complex causal interaction between properties of the cells (genomic/epigenomic state) and properties of the cellular/tissue context, within a particular individual within a particular timeframe. In the context of a complex, robust and genomically unstable system, it becomes less important –and maybe impossible- to pinpoint a specific causative initial factor (be it the genes, the genome, the stroma, and so on), and the notion of cause itself becomes elusive.
The debate reductionism/holism should be left aside, and the complex causal relations, not the initial causative factor, within the system should be addressed. This would be the paradigm shift envisaged by Marcum for system biology.You can see the presentation here.
Les Avants, Montreux, Switzerland Causation in Biomedical Sciences II
In questo seminario ho affrontato la questione della plausibilità etica della decisione della Autorità Britannica sulla Fertilizzazione e Embriologia Umana (HFEA) riguardante la permissibilità della ricerca su embrioni ibridi citoplasmatici (5 settembre 2007, http://www.hfea.gov.uk/en/1581.html). Inizialmente mostro come la maggior parte delle paure scatenate da questa decisione sono ingiustificate, poichè basate su una terminologia errata: ibridi e chimere infatti non hanno niente a che fare con la decisione dell’HFEA. Il termine corretto è invece ‘embrioni ibridi citoplasmatici’ o 'cibridi'. Quindi, richiamando la biologia sottostante la produzione dei cibridi, sottolineo come le cellule umane embrionali staminali ottenute attraverso trasferimento cellulare nucleare somatico (SCNT) tradizionale e interspecifico sono essenzialmente identiche. Affronto poi la questione concernente il razionale dell’uso di oociti animali non umani nel trasferimento cellulare nucleare somatico, e il problema etico della donazione di oociti umani per la ricerca. Dopo aver analizzato un’alternativa all’uso di oociti animali non umani nell’SCNT, e averla rigettata perchè non applicabile in pratica, affronto le questioni etiche concernenti i cibridi, compresa la giustificabilità della ricerca sugli embrioni umani a uno stadio precoce, che assumo come premessa. Concludo infine che la decisione dell’HFEA è eticamente giustificabile. Puoi vedere la presentazione pdf qui.
PhD meeting, Riva del Garda
In this seminar I addressed the issue whether the decision of the British Human Fertilisation and Embryology Authority on the permissibility of research on cytoplasmic hybrid embryos (5th September 2007, http://www.hfea.gov.uk/en/1581.html) is ethically plausible.
I first show how most of the fears triggered by this decision are unjustified, because based on a wrong terminology: hybrids and chimeras are not the entities referred in the HFEA decision, instead the correct term is ‘cytoplasmic hybrid embryos’ (cybrids).
I turn then to the question concerning the rationale of the use of non-human animal oocytes in SCNT, and address the ethical problem of the donation of human oocytes for research.
After analysing an alternative to the use of non-human animal oocytes in SCNT, and rejecting it because not practically feasible, I tackle the ethical issues concerning research on cybrids, including the justifiability of research on early human embryos, which I assume as the premise of my arguments. I conclude that the HFEA decision is indeed ethically justifiable. You can see the pdf presentation here.
University of Bologna, Master of Medical Biotechnology